Gefitinib Synthon

Gefitinib Synthon is an oral medication used for targeted therapy in certain types of cancer. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth.

Gefitinib Synthon is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its role in targeted cancer therapy.

Common effects of Gefitinib Synthon may include skin rash, diarrhea, and appetite loss. Some users might experience fatigue or nausea. These effects can vary from person to person and are not exhaustive.

Gefitinib Synthon should be handled with care, especially for those with pre-existing liver or kidney conditions. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication as directed to maintain its efficacy.

Gefitinib Synthon may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be considered, as it may affect the medication's effectiveness.